Media Coverage

December 1, 2009 Dr. Fahar Merchant, President & CEO, Protox therapeutics, presents at the Toronto Board of Trade
February 27, 2009 New shot may be best medicine for prostate cancer - Springfield, MO, KY3 NBC News
October 28, 2008 Dr. Fahar merchant, President & CEO, Protox therapeutics, interviewed on BTV
Mar 26, 2008 Dr. Fahar Merchant, President and CEO, Protox Therapeutics interiewed on BNN Small Caps
Mar 28, 2007 Dr. Fahar Merchant interviewed on BNN
July 1, 2006 Dr. Fahar Mechant featured on Market Matters Radio with host Michael Levy.
Mar 27, 2006 Dr. Fahar Mechant featured on CEO Clips on The Biography Channel
Mar 2, 2006 Cancer Research Institute starts first Phase I clinical trial,
New drug targets prostate cancer cells
Mar 2, 2006 Scott & White interview on CBS
Mar 1, 2006 Scott & White interview on NBC

What's New

August 11, 2010
Protox Reports Second Quarter 2010 Financial Results

June 2, 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.37
TRADE TIME:3:58PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.37
OPEN:$0.36
BID:$0.36
ASK:$0.37